EP2650007

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various autoimmune diseases

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    2.6.2009
  • :
    20.5.2015
  • :
    13002792.3
  • :
    1.6.2029
  • :
    Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various autoimmune diseases

2.6.2009
20.5.2015
  • :
    Xigen Inflammation Ltd.
  • :
    Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
  • :
    Bonny, Christophe
  • :
    Avenches, CH
  • :
    PCT/EP2008/004341
  • :
    30.5.2008
  • :
    WO
  • :
    A61K 38/01, A61K 38/03, A61K 38/04, A61P 9/00, A61P 11/00, A61P 17/00, A61P 25/00, A61P 31/12, A61P 37/00